Regeneron is buying 23andMe out of bankruptcy for $256 million todayheadline
© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use ...
Read moreDetailsTag: Regeneron Pharmaceuticals
Regeneron to buy bankrupt DNA testing firm 23andMe for $256 million
(Reuters) -Drugmaker Regeneron Pharmaceuticals will buy genetic testing firm 23andMe Holding for $256 million through a bankruptcy auction, the companies ...
Read moreDetailsRegeneron beats quarterly estimates on eczema drug demand; launches dividend program
(Reuters) - Regeneron Pharmaceuticals beat fourth-quarter sales and profit estimates on Tuesday, on continuing demand for its eczema treatment, Dupixent, ...
Read moreDetails
